Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

276

HTML

1625

Figures (1-6)

210

Tables (1-3)

190

Sum=2301

Feb 21, 2007 (publication date) through Nov 17, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Feb 21, 2007; 13(7): 1067-1073
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1067

Full Size Figure Download Figure

Figure 3 Serum albumin levels in 10 patients with chronic liver disease as a function of weeks after transplantation of autologous BMCs.

Citation: Lyra AC, Soares MBP, Silva LFMD, Fortes MF, Silva AGP, Mota ACA, Oliveira SA, Braga EL, Carvalho WA, Genser B, Santos RRD, Lyra LGC. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 2007; 13(7): 1067-1073
URL: https://www.wjgnet.com/1007-9327/full/v13/i7/1067.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i7.1067